Monteru Kid Tablets 10s are specially formulated chewable tablets combining Montelukast Sodium 5mg and Rupatadine Fumarate 5mg, designed to provide effective relief for childhood allergies and asthma‑related symptoms. This dual‑action formulation targets both histamine‑driven allergic reactions and leukotriene‑mediated airway inflammation, making it highly effective in controlling symptoms such as sneezing, runny nose, itchy eyes, coughing, wheezing, chest tightness, and airway swelling. Rupatadine acts as a long‑acting second‑generation antihistamine that blocks peripheral H1 receptors, reducing itching, nasal discharge, and other allergy manifestations. Montelukast, a leukotriene receptor antagonist, prevents airway narrowing by blocking cysteinyl‑leukotrienes, making it beneficial for asthma prevention, exercise‑induced bronchospasm, and allergic rhinitis. This combination provides comprehensive allergy and asthma control in children. Monteru Kid is administered orally, with the chewable form making it easy for children to take. It is indicated for managing seasonal and perennial allergic rhinitis, mild persistent asthma, and combined allergic airway diseases. The product is marketed in Kenya with a 10‑tablet pack size and is registered for pediatric use.
